IO Biotech
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $850 | $0 |
Gross Profit | -234 | -227 | 425 | -205 |
EBITDA | -25,612 | -22,584 | -26,724 | -26,299 |
EBIT | -25,846 | -22,811 | -26,943 | -26,504 |
Net Income | -26,217 | -22,421 | -31,333 | -24,015 |
Net Change In Cash | 0 | 0 | 850 | 0 |
Free Cash Flow | -19,848 | -23,099 | -19,636 | -20,818 |
Cash | 28,131 | 37,086 | 60,031 | 80,185 |
Basic Shares | 65,880 | 65,880 | 65,880 | 65,880 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -849 | -756 | -540 | |
EBITDA | -93,199 | -91,228 | -69,343 | -67,450 |
EBIT | -94,048 | -91,443 | -69,883 | -67,452 |
Net Income | -95,491 | -86,083 | -71,458 | -67,879 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -60,419 | |||
Free Cash Flow | -82,391 | -72,060 | -60,419 | -40,799 |
Cash | 60,031 | 143,193 | 142,590 | 211,531 |
Basic Shares | 65,880 | 43,539 | 28,815 | 28,815 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.40 |
2025-03-31 | -$0.34 |
2024-12-31 | -$0.48 |
